The EXPAND study: Efficacy and safety of rivaroxaban in Japanese patients with non-valvular atrial fibrillationHiroaki Shimokawa, Hiroshi Inoue, Wataru Shimizu et al.|International Journal of Cardiology|2018Cited by 48
Study Design and Baseline Characteristics of the EXPAND Study: Evaluation of Effectiveness and Safety of Xa Inhibitor, Rivaroxaban for the Prevention of Stroke and Systemic Embolism in a Nationwide Cohort of Japanese Patients Diagnosed as Non-Valvular Atrial FibrillationTakanori Ikeda, Hiroaki Shimokawa, Hirotsugu Atarashi et al.|The Tohoku Journal of Experimental Medicine|2016Cited by 14